SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-16-013931
Filing Date
2016-12-05
Accepted
2016-12-05 15:40:52
Documents
27
Period of Report
2011-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cobi_10q.htm 10-Q 344860
2 CERTIFICATION cobi_ex311.htm EX-31.1 7939
3 CERTIFICATION cobi_ex321.htm EX-32.1 3126
  Complete submission text file 0001477932-16-013931.txt   1181896

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT cobi-20111031.xml EX-101.INS 171364
5 XBRL TAXONOMY EXTENSION SCHEMA cobi-20111031.xsd EX-101.SCH 12851
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cobi-20111031_cal.xml EX-101.CAL 31672
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cobi-20111031_def.xml EX-101.DEF 5978
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cobi-20111031_lab.xml EX-101.LAB 85073
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cobi-20111031_pre.xml EX-101.PRE 56343
Mailing Address 9650 - 20 AVENUE EDMONTON A0 T6N 1G1
Business Address 9650 - 20 AVENUE EDMONTON A0 T6N 1G1 780-469-2975
COMPASS BIOTECHNOLOGIES INC. (Filer) CIK: 0001327238 (see all company filings)

IRS No.: 470930829 | State of Incorp.: NV | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 000-52057 | Film No.: 162033714
SIC: 2834 Pharmaceutical Preparations